Ronald J Korthuis Selected Research

Ronald J Korthuis Research Topics

Disease

28	Ischemia 01/2021 - 09/2002
9	Inflammation (Inflammations) 01/2020 - 06/2007
4	Brain Ischemia (Cerebral Ischemia) 08/2010 - 05/2006
3	Reperfusion Injury 01/2021 - 10/2010
3	Hypertension (High Blood Pressure) 01/2011 - 06/2007
2	Atherosclerosis 10/2020 - 01/2011
2	Sepsis (Septicemia) 01/2020 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 01/2012
2	Stroke (Strokes) 01/2012 - 05/2006
1	Carcinoma (Carcinomatosis) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 10/2020
1	Acute Lung Injury 01/2020
1	Lung Injury 01/2020
1	Hemorrhagic Shock 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Myocardial Infarction 01/2012
1	Rupture 01/2012
1	Binge Drinking 01/2012
1	Ischemic Stroke 01/2012
1	Asthma (Bronchial Asthma) 01/2011
1	Hypersensitivity (Allergy) 01/2011
1	Arthritis (Polyarthritis) 01/2011
1	Abdominal Aortic Aneurysm 01/2011
1	Body Weight (Weight, Body) 05/2006

Drug/Important Bio-Agent (IBA)

9	Ethanol (Ethyl Alcohol)IBA 01/2012 - 09/2002
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
5	Heme Oxygenase-1IBA 11/2017 - 11/2005
3	Peroxidase (Myeloperoxidase)IBA 01/2020 - 01/2012
3	CalciumIBA 12/2016 - 01/2012
3	sodium bisulfide (NaHS)IBA 01/2012 - 11/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2011 - 01/2007
3	salicylhydroxamic acid (SHAM)IBA 04/2011 - 12/2004
2	Plasminogen Activator Inhibitor 1IBA 01/2021 - 01/2018
2	LipidsIBA 01/2020 - 01/2019
2	Oxidants (Oxidizing Agents)IBA 11/2017 - 04/2003
2	Adenosine Triphosphatases (ATPase)IBA 12/2016 - 01/2012
2	Soluble Guanylyl CyclaseIBA 01/2016 - 08/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 05/2006
2	Adenosine (Adenocard)FDA LinkGeneric 01/2014 - 03/2007
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2012 - 09/2011
2	AICA ribonucleotide (ZMP)IBA 04/2011 - 02/2009
2	erucylphosphocholineIBA 04/2011 - 03/2007
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2011 - 02/2009
2	PolyphenolsIBA 05/2009 - 04/2003
2	acetovanillone (apocynin)IBA 10/2007 - 05/2006
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2007 - 05/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2007 - 01/2007
2	P-SelectinIBA 04/2005 - 12/2004
1	Caveolin 2IBA 01/2021
1	ApolipoproteinsIBA 10/2020
1	Apolipoproteins E (ApoE)IBA 10/2020
1	Insulin (Novolin)FDA Link 10/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2020
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2020
1	Tight Junction ProteinsIBA 10/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	N-acetyllysyltyrosylcysteine amideIBA 01/2020
1	HydrazinesIBA 01/2020
1	Mast Cell StabilizersIBA 01/2020
1	ChemokinesIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	AldehydesIBA 01/2020
1	CytokinesIBA 01/2020
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 01/2020
1	ChloridesIBA 01/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019
1	Vasoconstrictor AgentsIBA 01/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	NS 1619IBA 11/2017
1	4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acidIBA 01/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016
1	NitratesIBA 08/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2012
1	PotassiumIBA 01/2012
1	Adenosine Triphosphate (ATP)IBA 01/2012
1	Peptide Hydrolases (Proteases)FDA Link 01/2011
1	serglycinIBA 01/2011
1	Proteoglycans (Proteoglycan)IBA 01/2011
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 11/2010
1	ApaminIBA 11/2010
1	paxillineIBA 11/2010
1	TRAM 34IBA 11/2010
1	AntioxidantsIBA 10/2010
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 08/2010
1	Matrix Metalloproteinases (MMPs)IBA 07/2010
1	EndotoxinsIBA 02/2009
1	Amyloid beta-PeptidesIBA 02/2009
1	AMP-Activated Protein KinasesIBA 02/2009
1	Angiotensin IIIBA 06/2007
1	Neuroprotective AgentsIBA 05/2006
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 05/2006
1	Protein Kinase CIBA 04/2005
1	Monoclonal AntibodiesIBA 12/2004
1	Xanthine OxidaseIBA 04/2003
1	ResveratrolIBA 04/2003
1	HypoxanthineIBA 04/2003

Therapy/Procedure

1	Ligation 01/2020
1	Punctures 01/2020
1	Oral Administration 05/2009